Related Experiment Video

Updated: Apr 28, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

703

[Opportunities of electrogastroenterography in pediatric gastroenterological practice]

T M Prygunova, I V Sadovnikova, L G Lazareva

    Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology
    |June 18, 2014
    PubMed

    Insights

    Electrogastroenterography (EGEG) can help personalize treatments for children with inflammatory gastrointestinal diseases. This noninvasive method assesses gut motility, aiding in therapy adjustments for conditions like chronic gastritis.

    Area of Science:

    • Pediatric Gastroenterology
    • Medical Diagnostics

    Context:

    • Inflammatory diseases of the gastrointestinal tract are common in children.
    • Accurate diagnosis and individualized treatment are crucial for managing pediatric GI conditions.
    • Current diagnostic methods may have limitations in assessing gastrointestinal motility.

    Purpose:

    • To explore the utility of electrogastroenterography (EGEG) in evaluating children with inflammatory gastrointestinal diseases.
    • To determine if EGEG can aid in personalizing treatment strategies for this patient group.
    • To assess the feasibility and tolerability of EGEG in pediatric patients.

    Summary:

    • Electrogastroenterography (EGEG) was performed on five children (10-15 years) diagnosed with chronic gastritis.
    • The study investigated motor-evacuation function and hypersecretory reactions using standard electrodes.
    • Results indicated accelerated gastrointestinal motor-evacuation function in all participants.

    Impact:

    • EGEG is a noninvasive, well-tolerated diagnostic tool with no contraindications for pediatric use.
    • The method allows for repeated examinations across various patient ages and conditions.
    • EGEG findings can guide and correct therapeutic interventions for pediatric gastrointestinal disorders.
    Abstract

    More Related Videos

    Electroretinogram Recording for Infants and Children under Anesthesia to Achieve Optimal Dark Adaptation and International Standards08:38

    Electroretinogram Recording for Infants and Children under Anesthesia to Achieve Optimal Dark Adaptation and International Standards

    Published on: September 3, 2020

    5.5K
    Guidelines for Elective Pediatric Fiberoptic Intubation11:19

    Guidelines for Elective Pediatric Fiberoptic Intubation

    Published on: January 17, 2011

    17.5K

    Related Concept Videos

    Endoscopic Procedures I: Esophagogastroduodenoscopy01:29

    Endoscopic Procedures I: Esophagogastroduodenoscopy

    An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
    During an EGD, the endoscope can be used to:
    2.4K
    Endoscopic Procedures V: ERCP01:26

    Endoscopic Procedures V: ERCP

    Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
    Patient...
    7.2K
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    955
    Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

    Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

    Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
    Nasointestinal Feeding
    Nasointestinal feeding involves placing a tube...
    2.0K
    Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

    Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

    Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
    Sigmoidoscopy
    Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
    1.2K
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    405